Abstract
The latest news about global vaccine research and development shows that we have made great progress in vaccine development. However, in China, a large population of people are hesitant to get vaccinated due to various reasons. In this article, we focus on how to address people's hesitancy on the coronavirus disease 2019 (COVID-19) vaccine. It is important that governments fully prepare for both pre-risk prevention and post-event relief to promote the vaccination program's smooth implementation. In particular, the government should establish and improve a national vaccine injury compensation program in response to COVID-19's adverse events following immunization. Only through multilateral efforts and comprehensive measures can the people's confidence in vaccination improve and their worries about the future be relatively eased.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
